 Onconova Therapeutics, Inc. NASDAQ:ONTX Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Bruce Mackle - Investor Relations, LifeSci Advisors Steve Fruchtman - President Chief Executive Officer Mark Gelder - Chief Medical Officer Mark Guerin - Chief Operating Officer Chief Financial Officer Conference Call Participants Charles Zhu - Guggenheim Chun Lung - Ladenburg Robert LeBoyer - Noble Capital Markets Operator Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Second Quarter 2022 Financial Results and Business Update Conference Call. 